Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
Close

AstraZeneca PLC (AZN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1,432.0 +6.0    +0.42%
05:16:32 - Real-time Data. Currency in SEK ( Disclaimer )
Type:  Equity
Market:  Sweden
ISIN:  GB0009895292 
S/N:  1549109281
  • Volume: 52,046
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 1,424.5 - 1,437.0
AstraZeneca 1,432.0 +6.0 +0.42%

AZN Balance Sheet

 
Featured here, the Balance Sheet for AstraZeneca PLC, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2022
31/12
 2022
30/09
 2022
30/06
 2022
31/03
Total Current Assets 22593 20224 20917 22647
Cash and Short Term Investments 6243 4522 4887 5823
Cash - - - -
Cash & Equivalents 6166 4458 4817 5762
Short Term Investments 64 64 70 61
Total Receivables, Net 11252 10061 9612 9050
Accounts Receivables - Trade, Net 10521 9336 8908 8683
Total Inventory 4699 5078 6220 7624
Prepaid Expenses - - - -
Other Current Assets, Total 399 563 198 150
Total Assets 96483 94185 96579 100273
Property/Plant/Equipment, Total - Net 9449 9227 9627 10015
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 19820 19707 19821 19963
Intangibles, Net 39307 39585 39900 41265
Long Term Investments 1142 1102 1180 1237
Note Receivable - Long Term 731 725 704 367
Other Long Term Assets, Total 909 904 994 951
Other Assets, Total -1485 -920 1016 2980
Total Current Liabilities 26293 24850 21815 22740
Accounts Payable 2550 16842 16983 17040
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 350 743 747 805
Current Port. of LT Debt/Capital Leases 1188 5795 2563 2348
Other Current liabilities, Total 3814 1470 1522 2547
Total Liabilities 59425 59031 60628 63914
Total Long Term Debt 24633 24737 28078 29592
Long Term Debt 23908 24069 27393 28868
Capital Lease Obligations 725 668 685 724
Deferred Income Tax 2944 3479 5275 5626
Minority Interest 21 20 19 19
Other Liabilities, Total -4057 846 386 854
Total Equity 37058 35154 35951 36359
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 387 387 387 387
Additional Paid-In Capital 35155 35137 35134 35131
Retained Earnings (Accumulated Deficit) -574 -2471 -1657 -1228
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -1604 2101 2087 2069
Total Liabilities & Shareholders' Equity 96483 94185 96579 100273
Total Common Shares Outstanding 1549.8 1548 1549 1548
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Attila Szabo
Attila Szabo Mar 01, 2022 2:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Pfizer and Moderna fell big time in share prices, while Astra kept it’s stable 9ish. How?
Reply
3 1
Report
Jim buck
Jim buck Mar 01, 2022 2:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it's at 10k now
Reply
3 0
Report
igei chibuzor
igei chibuzor Mar 01, 2022 2:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
money to get
Reply
2 0
Report
igei chibuzor
igei chibuzor Mar 01, 2022 2:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hello please help you
Reply
1 1
Report
lee taylor
lee taylor Mar 01, 2022 2:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Attila, AZ & Pfizer are pharmaceutical companies that makes medicines. They are not just providers of vaccines. At present, and for the foreseeable future, the AZ science is much stronger than that of Pfizer, and similar to Merck, which is another pharmaceutical company that has grown materially this year. I am long on AZ and Merck.
Reply
1 0
Report
Lucas Whipps
Lucas Whipps Sep 07, 2021 5:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
An attractive PRE-IPO called SpectrumX based in England plans to launch by November and i'm very hopeful of this particular investment. Clinical trials for their Covid-19 respiratory treatment are now in phase 2 of development which will be a game changer once hospitals get their hands on it. This will not be factored into the company valuation when listed. So if the trials are successful the market value will rocket. Thats why im seriously excited about this IPO and i don't usually go near PRE IPO's.
Reply
3 4
Report
Jim buck
Jim buck Sep 07, 2021 5:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how's it doing today
Reply
0 0
Report
Jim buck
Jim buck Sep 07, 2021 5:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how's it doing today
Reply
0 0
Report
Market is Right
MarketisRight Aug 17, 2021 6:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
50
Reply
3 0
Report
Market is Right
MarketisRight Aug 17, 2021 6:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
*50000
Reply
0 0
Report
Dũng Kim Tu Thap MAXF
Dũng Kim Tu Thap MAXF Jul 17, 2021 4:08PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
19970410🌍 10000%
Reply
1 0
Report
Kurt Wilson
Kurt Wilson Jun 03, 2021 3:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Most of vunerable demographic now vaccinated. Will younger people accept the jab or will potential health concerns outweigh the potential benefits. I'm short AstraZeneca
Reply
1 5
Report
Long Trading
Long Trading Apr 22, 2021 4:39PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
net short positions available on the PNC Borsa app
Reply
0 0
Report
Woon soo Lee
Woon soo Lee Mar 28, 2021 4:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Above 7500 to 9750 soon these weeks bullish sentiments business development infrastructure expenditures stimulus package cause its stance growth economics of scales
Reply
4 2
Report
ali akhzari
ali akhzari Mar 28, 2021 4:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
you are nostetadamoos
Reply
1 1
Report
danbalao danbalao
danbalao Mar 23, 2021 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
may be buy or sell the stock but be very cautious before being vaccinated : some serious cases in Europe especially with young to intermediate people
Reply
4 11
Report
Show previous replies (1)
GP GAP
GP GAP Mar 23, 2021 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
blabla bla  are u scientist? or just repeating hear?
Reply
2 1
Report
danbalao danbalao
danbalao Mar 23, 2021 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jenny Gough Im not anti vaccine at all. Ill take the pfizer moderna and even the sputnik asap. The fact is that the european health autority has recommended not to use the astra for people under 55. My message is informative, yours is insulting.
Reply
2 1
Report
danbalao danbalao
danbalao Mar 23, 2021 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
GP GAP Yes Im chief nurse teacher in a very big hospital. Not specialised in vaccine but i know a little bit about heath. And im a pro vaccine. But the rule we were givenby health autorities  was : Astra not for people under 55.
Reply
2 1
Report
GP GAP
GP GAP Mar 23, 2021 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thanks for the advise.
Reply
0 0
Report
ali akhzari
ali akhzari Mar 23, 2021 6:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jenny Gough like dada
Reply
1 0
Report
Jas Chana
Jock12 Mar 22, 2021 7:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is moving now....at last! US approval coming.
Reply
1 1
Report
Antonio Kundurakis
Antonio Kundurakis Mar 18, 2021 7:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The cause behind the suspected vaccine side effects has been found. This is the opinion of a Norwegian expert group that examined the three healthcare employees who were admitted to hospital after being vaccinated with Astra Zeneca's vaccine. The vaccine triggered a strong immune reaction in the people. - I see no other reason than that it is the vaccine that triggers it, says the chief physician and professor Pål Andre Holme to VG. Sell off coming
Reply
4 5
Report
Jenny Gough
Jenny Gough Mar 18, 2021 7:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I guess that puts this Professor at odds with all the others looking at the data then.   Strange they were all healthcare employees.
Reply
1 0
Report
GP GAP
GP GAP Mar 18, 2021 7:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
u shorting?
Reply
0 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email